Novartis honors scientists for outstanding contributions to research and development


The Novartis Leading Scientist Awards - granted this year for the seventh time - are part of the company's global VIVA (Vision, Innovation, Value, Achievement) program, which was established in 1998 to promote creativity and innovation in research and development. The awards are designed to recognize outstanding contributions made by scientists working in research and development and carry a prize of CHF 25,000, as well as the right to use the title "Novartis Leading Scientist."
 
Please find full press release attached.
 
 
 
About Novartis
Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health. In 2003, the Group's businesses achieved sales of USD 24.9 billion and a net income of USD 5.0 billion. The Group invested approximately USD 3.8 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 80,000 people and operate in over 140 countries around the world. For further information please consult http://www.novartis.com.
 
For pictures of the award ceremony please consult URL:
 
 
Contacts
 
Fintan R. Steele, Ph.D.
Novartis Institutes for BioMedical Research
Tel +1 617 871 3100
or  +1 617 470 4196
 
Satoshi Sugimoto
Novartis Global Media Relations
Tel +41 61 324 61 29
or +41 61 324 22 00

Attachments

Press Release (PDF)